MedImmune: Changing the US Licensing Landscape

Intellectual Asset Management
Summer 2007

The article, written by John D. Carlin and Dennis Gregory, discusses the implications of the recent Supreme Court decision in MedImmune v. Genentech on patent licensing negotiations. MedImmune permits far more frequent and easy challenges to licensed patents by licensees. The article focuses on the pitfalls potential licensors may now face and offers strategies to avoid those problems.

View Attachment (PDF)